Extension of a Study of Allogeneic Hematopoietic Stem Cell Transplantation From One Haplotype Mismatch Related Donor or From an Unrelated Donor to Younger Patients Eligible for Reduced-intensity Conditioning Regimen
Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Institut Paoli-Calmettes
Age
18–55
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Patients with hematological malignancy
Age\<55 years
HCT-CI score ≥ 3 or non-eligible for myeloablative regimen
Patients without a matched related donor
Patients eligible for an allogeneic HSCT from an alternative donor
Able to comply with the protocol
Written informed consent
Patient affiliated to the national "Social Security" regimen or beneficiary of this regimen
You may not be if
Clinical or biological contraindication to allogeneic HSCT
Pregnant or breast-feeding women.
Patient considered socially or psychologically unable to comply with the treatment and the required medical follow-up.
Severe concomitant disease
Clareo Health | Extension of a Study of Allogeneic Hematopoietic Stem Cell Transplantation From One Haplotype Mismatch Related Donor or From an Unrelated Donor to Younger Patients Eligible for Reduced-intensity Conditioning Regimen
